Industry Updates from the Field of Stem Cell Research and Regenerative Medicine in December 2019
February 2020
in “
Regenerative Medicine
”
TLDR Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.
In December 2019, significant advancements were made in stem cell research and regenerative medicine, with notable collaborations and studies. Follica reported a 44% improvement in visible hair count in 19 male participants with androgenetic alopecia after 3 months, planning a Phase III study in 2020. Other developments included partnerships like StemoniX and Atomwise targeting Rett syndrome, and Novoheart with Harvard for heart model technologies. Aspen Neuroscience launched to develop cell therapies for Parkinson’s disease, and Jasper Therapeutics evaluated JSP191 in over 80 individuals for safer stem cell transplants. Bristol-Myers Squibb's CAR T-cell therapy showed promise in lymphoma, and collaborations with Bluebird Bio were positive for multiple myeloma. Celularity and Gamida Cell advanced NK cell therapies for cancer. These updates underscored the innovation and collaboration in the field.
